Baseline numbers of platelet-derived and total thrombogenic microvesicles significantly correlated with increases in white matter hyperintensity volume over 48 months (p=0.03).
Cohort (n=95)
Are baseline thrombogenic microvesicles and platelet activation markers associated with white matter hyperintensity progression in recently menopausal women?
Baseline platelet-derived thrombogenic microvesicles are associated with the progression of white matter hyperintensities in recently menopausal women, suggesting a role for in vivo platelet activation.
p-value: p=0.03
OBJECTIVE: To determine the association of conventional cardiovascular risk factors, markers of platelet activation, and thrombogenic blood-borne microvesicles with white matter hyperintensity (WMH) load and progression in recently menopausal women. METHODS: Women (n = 95) enrolled in the Mayo Clinic Kronos Early Estrogen Prevention Study underwent MRI at baseline and at 18, 36, and 48 months after randomization to hormone treatments. Conventional cardiovascular risk factors, carotid intima-medial thickness, coronary arterial calcification, plasma lipids, markers of platelet activation, and thrombogenic microvesicles were measured at baseline. WMH volumes were calculated using a semiautomated segmentation algorithm based on fluid-attenuated inversion recovery MRI. Correlations of those parameters with baseline WMH and longitudinal change in WMH were adjusted for age, months past menopause, and APOE ε4 status in linear regression analysis. RESULTS: At baseline, WMH were present in all women. The WMH to white matter volume fraction at baseline was 0.88% (0.69%, 1.16%). WMH volume increased by 122.1 mm(3) (95% confidence interval: -164.3, 539.5) at 36 months (p = 0.003) and 155.4 mm(3) (95% confidence interval: -92.13, 599.4) at 48 months (p < 0.001). These increases correlated with numbers of platelet-derived and total thrombogenic microvesicles at baseline (p = 0.03). CONCLUSION: Associations of platelet-derived, thrombogenic microvesicles at baseline and increases in WMH suggest that in vivo platelet activation may contribute to a cascade of events leading to development of WMH in recently menopausal women.
Raz et al. (2013) conducted a cohort in White matter hyperintensities in recently menopausal women (n=95). Platelet-derived and total thrombogenic microvesicles was evaluated on Longitudinal change in white matter hyperintensity (WMH) volume (p=0.03). Baseline numbers of platelet-derived and total thrombogenic microvesicles significantly correlated with increases in white matter hyperintensity volume over 48 months (p=0.03).